Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews
- PMID: 34607052
- PMCID: PMC8586735
- DOI: 10.1016/j.socscimed.2021.114450
Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of systematic reviews
Abstract
Background: Alcohol's effects on heart health is the site of a major scientific controversy. We conducted a co-authorship network analysis of systematic reviews on the impacts on alcohol on cardiovascular disease (CVD) in order to investigate patterns of co-authorship in the literature, with particular attention given to industry funding.
Methods: We used Epistemonikos to identify systematic reviews. Review characteristics, influential authors, co-authorship subnetworks, prior histories of alcohol industry funding, study outcomes and citations were investigated.
Results: 60 systematic reviews with 231 unique authors met our inclusion criteria. 14 systematic reviews were undertaken by authors with histories of alcohol industry funding, including 5 that were funded directly by the alcohol industry itself. All 14 such reviews identified a cardioprotective effect of alcohol. These formed distinct co-authorship subnetworks within the literature. Of reviews by authors with no prior histories of alcohol industry funding, the findings were mixed, with 54% (25/46) concluding there was evidence of health protective effects. These two groups of reviews differed in other respects. Those with industry funding were more likely to study broader outcomes such as 'cardiovascular disease' or 'coronary heart disease' as opposed to specific CVD issues such as hypertension or stroke (93% [13/14] versus 41% [19/46]) (chi-squared 12.4, p < 0.001) and have more included studies (mean of 29 versus 20). They were also more widely cited by others. Over time the proportions of systematic reviews on CVD and alcohol undertaken by authors with no prior histories of alcohol industry funding has increased.
Conclusions: Systematic reviews undertaken by authors with histories of alcohol industry funding were more likely to study broader outcomes, and be cited more widely, and exclusively reported favorable conclusions.
Keywords: Alcohol drinking; Alcohol industry; Authorship; Bibliometrics; Cardiovascular diseases; Conflict of interest; Research support; Systematic reviews.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
All authors have completed the ICMJE uniform disclosure form at
Figures


Similar articles
-
Alcohol, cardiovascular disease and industry funding: A co-authorship network analysis of epidemiological studies.Addict Behav. 2024 Apr;151:107932. doi: 10.1016/j.addbeh.2023.107932. Epub 2023 Dec 2. Addict Behav. 2024. PMID: 38103279
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Has industry funding biased studies of the protective effects of alcohol on cardiovascular disease? A preliminary investigation of prospective cohort studies.Drug Alcohol Rev. 2015 Jan;34(1):58-66. doi: 10.1111/dar.12125. Epub 2014 Mar 7. Drug Alcohol Rev. 2015. PMID: 24602075 Free PMC article.
-
Academic Influence and Industry Funding in Acellular Dermal Matrix Research: A Co-authorship Network Analysis.Ann Plast Surg. 2025 May 1;94(5S Suppl 3):S465-S468. doi: 10.1097/SAP.0000000000004164. Ann Plast Surg. 2025. PMID: 40310011
-
Industry Involvement and Transparency in the Most Cited Clinical Trials, 2019-2022.JAMA Netw Open. 2023 Nov 1;6(11):e2343425. doi: 10.1001/jamanetworkopen.2023.43425. JAMA Netw Open. 2023. PMID: 37962883 Free PMC article. Review.
Cited by
-
Alcohol and Cardiovascular Disease: Helpful or Hurtful.Rev Cardiovasc Med. 2023 Apr 19;24(4):121. doi: 10.31083/j.rcm2404121. eCollection 2023 Apr. Rev Cardiovasc Med. 2023. PMID: 39076262 Free PMC article. Review.
-
Evolution of the major alcohol companies key global policy vehicle through the prism of tax records 2011-19.Global Health. 2023 May 25;19(1):34. doi: 10.1186/s12992-023-00933-w. Global Health. 2023. PMID: 37226209 Free PMC article.
-
Randomised study of the effects of sense of entitlement and conflict of interest contrarianism on researcher decision-making to work with the alcohol industry.BMC Public Health. 2024 Jun 24;24(1):1680. doi: 10.1186/s12889-024-18961-5. BMC Public Health. 2024. PMID: 38914989 Free PMC article.
-
The Commercial Determinants of Health and Evidence Synthesis (CODES): methodological guidance for systematic reviews and other evidence syntheses.Syst Rev. 2023 Sep 14;12(1):165. doi: 10.1186/s13643-023-02323-0. Syst Rev. 2023. PMID: 37710334 Free PMC article.
-
Industry involvement in evidence production for genomic medicine: A bibliometric and funding analysis of decision impact studies.PLoS One. 2023 Apr 27;18(4):e0285122. doi: 10.1371/journal.pone.0285122. eCollection 2023. PLoS One. 2023. PMID: 37104298 Free PMC article.
References
-
- Arredondo Bruce A., Del Risco Morales O. Cardio protector action of the alcohol moderated usage. Rev medica electron. 2014;36(2):181–194.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous